MassMutual Private Wealth & Trust’s Myriad Genetics MYGN Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$228	Hold	40	–	–	﹤0.01%	2357
2026 Q1	$180	Sell	40 -88	-69%	-$459	﹤0.01%	2328
2025 Q4	$787	Sell	128 -35	-21%	-$254	﹤0.01%	2183
2025 Q3	$1.18K	Buy	163 +40	+33%	+$237	﹤0.01%	2118
2025 Q2	$653	Sell	123 -19	-13%	-$112	﹤0.01%	2200
2025 Q1	$1.26K	Buy	142 +56	+65%	+$673	﹤0.01%	2055
2024 Q4	$1.18K	Buy	+86	New	+$1.59K	﹤0.01%	1983
2023 Q3	–	Sell	-267	Closed	-$6.19K	–	2014
2023 Q2	$6.19K	Hold	267	–	–	﹤0.01%	1143
2023 Q1	$6.2K	Buy	+267	New	+$5.42K	﹤0.01%	1096
2014 Q2	–	Sell	-33	Closed	-$1.13K	–	580
2014 Q1	$1.13K	Buy	+33	New	+$1.02K	﹤0.01%	557

Other funds holding MYGN

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

OAM

OP Asset Management Helsinki $9.38B AUM 42.35% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

MFG

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

ICP

Impact Capital Partners Greenwood Village, Colorado $367M AUM 28.36% 1-Year Est. Return

Atria Investments Charlotte, North Carolina $9.98B AUM 26.5% 1-Year Est. Return

CFB

Cullen/Frost Bankers San Antonio, Texas $10.1B AUM 29.18% 1-Year Est. Return

MassMutual Private Wealth & Trust's MYGN Position: Q2 2026 in Review

MassMutual Private Wealth & Trust held its Myriad Genetics (MYGN) position steady in Q2 2026 at 40 shares worth $228. The position accounts for ﹤0.01% of the portfolio, ranked #2357.

MassMutual Private Wealth & Trust first reported a position in MYGN in Q1 2014 and has held it in 10 quarters since. The position peaked at $6.2K in Q1 2023. 32 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.

MassMutual Private Wealth & Trust held 40 shares of Myriad Genetics worth $228 as of Q2 2026.
MassMutual Private Wealth & Trust left its Myriad Genetics share count unchanged in Q2 2026.
Myriad Genetics made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #2357 holding.
MassMutual Private Wealth & Trust first reported a position in Myriad Genetics in Q1 2014 and has held it in 10 quarters since.
MassMutual Private Wealth & Trust's Myriad Genetics position peaked at $6.2K in Q1 2023.
32 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.